Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
business
business sponsored company news
archive
medical
articles containing video clips
colloids
coronavirus
dosage forms
drug delivery devices
gels
histopathology
infectious causes of cancer
male genital neoplasia
medicine
neoplastic and hyperplastic prostate disorders
physical chemistry
prostate cancer
research
rtt
american medical association
anaerobic digestion
biodegradable waste management
biodegradation
companies based in minneapolis
companies established in 1895
companies listed on the new york stock exchange
fda
government
illinois
investment banks
medical and health professional associations in chicago
minnesota
organizations established in 1847
supraorganizations
technology & solutions
u.s. bancorp
What
announced
22
×
risk
22
×
medical
company
augmenix
develops
hydrogels
manufactures
organs
press
protect
radiotherapy
release
sells
separate
technology
absorbable
proprietary
today
announces
hydrogel
prostate
spaceoar
cancer
new
healthcare
annual
patients
american
conference
data
present
radiation
results
treated
treatment
analysis
association
blood
clinical
Language
unset
Current search:
risk
×
announced
×
@thefastmode.com
9 months ago
Asimily Integrates With CCM® for IoT Security Monitoring for Healthcare
@slashgear.com
2 years ago
Pfizer’s “overwhelming” COVID-19 pill results fuel home treatment hopes
@slashgear.com
3 years ago
Denmark to cull all mink after warning about ‘serious’ virus mutation risk
@slashgear.com
4 years ago
Blood pressure medication recall expands over cancer risk
@slashgear.com
5 years ago
Popular blood sugar drug slashes kidney failure risk in diabetics
@venturebeat.com
6 years ago
Augmenix to Present at the 36th Annual J.P. Morgan Healthcare Conference
@venturebeat.com
6 years ago
Augmenix® Announces Medicare Reimbursement Rates for the new CPT Code 55874, which will be used to bill SpaceOAR® Hydrogel, Effective January 2018
@venturebeat.com
6 years ago
Augmenix Announces Positive Clinical Trial Results Demonstrating Efficacy of SpaceOAR
@venturebeat.com
6 years ago
Augmenix to Unveil New Clinical Data on its Innovative Absorbable Hydrogel Technology at the 59th Annual Meeting of the American Society for Radiation Oncology
@venturebeat.com
6 years ago
NICE Announces Interventional Procedure Guidance Supporting Use of Hydrogel Spacer in Treatment of Prostate Cancer in the UK
@venturebeat.com
6 years ago
Augmenix, Inc. Announces Medicare Administrative Contractor Palmetto Coverage for SpaceOAR® Hydrogel
@venturebeat.com
6 years ago
Augmenix Announces First Prostate Cancer Patients Treated with SpaceOAR® Hydrogel in Israel
@venturebeat.com
6 years ago
Augmenix Announces First Prostate Cancer Patient Treated with SpaceOAR® Hydrogel in New Zealand
@venturebeat.com
6 years ago
SpaceOAR® System Receives Shonin Approval in Japan
@venturebeat.com
6 years ago
Augmenix Announces First Prostate Cancer Patient Treated with SpaceOAR® Hydrogel in Canada
@venturebeat.com
7 years ago
Phase 3 Trial Data Show Use of SpaceOAR® Hydrogel Helps Maintain Erectile Function Following Prostate Cancer Radiation Treatment
@venturebeat.com
7 years ago
Augmenix Announces Positive Three-Year Long-Term Data Highlighting Benefits of SpaceOAR® Hydrogel Spacer for Patients with Prostate Cancer
@venturebeat.com
7 years ago
Augmenix To Present at the 35th Annual J.P. Morgan Healthcare Conference
@venturebeat.com
7 years ago
Augmenix to Present at the Annual Piper Jaffray Healthcare Conference on Wednesday, November 30
@venturebeat.com
7 years ago
Augmenix Announces New Category 1 CPT® Code from the American Medical Association for Periprostatic Implantation of Biodegradable Material
@theverge.com
7 years ago
Zika infection late in pregnancy doesn't cause brain defects, study says
@theverge.com
8 years ago
Google AI group that conquered Go is now taking on healthcare